Endovia Health Sciences, Inc. (EDVA)
Endovia Health Sciences is a diversified cannabinoid-based health sciences platform. The company's strategy focuses on three main areas: commercializing differentiated cannabinoid-based pharmaceutical products internationally, advancing cannabinoid-based human and veterinary therapeutics through U.S. regulatory pathways, and developing consumer wellness and beverage products. This marks a strategic transformation from its prior operations as a beverage company.
Sector: Beverages
Industry: Medical - Care Facilities
Endovia Health Sciences, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 11.08M shares outstanding
No company description available.
Leadership
Brady Cobb
Interim Chief Executive Officer & Director
Francis Knuettel II
Director
Frederick William (“Bill”) Caple
Chairman of the Board
Martin Scott
Interim CFO, Principal Financial & Accounting Officer
Employees
--
Country
--
Sector
Healthcare
Website
--
| Name | Shares | % | Source |
|---|---|---|---|
C/M Capital Partners, LP · joint filing· may incl. warrants· filed Oct 2026 | 797.6K | 7.2% | 13G |
Devereux William T · may incl. warrants· filed Oct 2025 | 251.3K | 2.3% | 13D |
Yorke Justin W · may incl. warrants· filed Oct 2025 | 227.0K | 2.0% | 13D |
Caple Frederick William · may incl. warrants· filed Oct 2025 | 191.9K | 1.7% | 13D |
Meissner William R. · may incl. warrants· filed Oct 2025 | 188.1K | 1.7% | 13D |
Fore Thomas Butler · filed Oct 2025 | 0+187.5K via warrants | 1.7% | 13D |
JANE STREET GROUP, LLC | 87.1K | 0.8% | 13F |
Phraction Management LLC | 50.3K | 0.5% | 13F |
Tong Magdalene · filed Oct 2025 | 0+50.0K via warrants | 0.5% | 13G |
Nistico Robert · may incl. warrants· filed Oct 2025 | 45.1K | 0.4% | 13D |
based on 11.08M shares outstanding
30d Avg
904.28K
60d Avg
3.69M
90d Avg
3.43M